Cited 0 times in Scipus Cited Count

Non-Arteritic Ischemic Optic Neuropathy Following COVID-19 Vaccination in Korea: A Case Series

DC Field Value Language
dc.contributor.authorMoon, Y-
dc.contributor.authorJung, JH-
dc.contributor.authorShin, HJ-
dc.contributor.authorChoi, DG-
dc.contributor.authorPark, KA-
dc.contributor.authorJeon, H-
dc.contributor.authorLee, BJ-
dc.contributor.authorKim, SJ-
dc.contributor.authorOh, SY-
dc.contributor.authorAhn, H-
dc.contributor.authorChung, SA-
dc.contributor.authorKim, US-
dc.contributor.authorLee, HJ-
dc.contributor.authorLee, JY-
dc.contributor.authorChoi, YJ-
dc.contributor.authorKorean Neuro-Ophthalmology Society-
dc.date.accessioned2023-05-04T06:41:42Z-
dc.date.available2023-05-04T06:41:42Z-
dc.date.issued2023-
dc.identifier.issn1011-8934-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/25303-
dc.description.abstractBackground: To report the clinical manifestations of non-arteritic anterior ischemic optic neuropathy (NAION) cases after coronavirus disease 2019 (COVID-19) vaccination in Korea. Methods: This multicenter retrospective study included patients diagnosed with NAION within 42 days of COVID-19 vaccination. We collected data on vaccinations, demographic features, presence of vascular risk factors, ocular findings, and visual outcomes of patients with NAION. Results: The study included 16 eyes of 14 patients (6 men, 8 women) with a mean age of 63.5 ± 9.1 (range, 43–77) years. The most common underlying disease was hypertension, accounting for 28.6% of patients with NAION. Seven patients (50.0%) had no vascular risk factors for NAION. The mean time from vaccination to onset was 13.8 ± 14.2 (range, 1–41) days. All 16 eyes had disc swelling at initial presentation, and 3 of them (18.8%) had peripapillary intraretinal and/or subretinal fluid with severe disc swelling. Peripapillary hemorrhage was found in 50% of the patients, and one (6.3%) patient had peripapillary cotton-wool spots. In eight fellow eyes for which we were able to review the fundus photographs, the horizontal cup/disc ratio was less than 0.25 in four eyes (50.0%). The mean visual acuity was logMAR 0.6 ± 0.7 at the initial presentation and logMAR 0.7 ± 0.8 at the final visit. Conclusion: Only 64% of patients with NAION after COVID-19 vaccination have known vascular and ocular risk factors relevant to ischemic optic neuropathy. This suggests that COVID-19 vaccination may increase the risk of NAION. However, overall clinical features and visual outcomes of the NAION patients after COVID-19 vaccination were similar to those of typical NAION.-
dc.language.isoen-
dc.subject.MESHAged-
dc.subject.MESHCOVID-19-
dc.subject.MESHCOVID-19 Vaccines-
dc.subject.MESHFemale-
dc.subject.MESHHumans-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHOptic Neuropathy, Ischemic-
dc.subject.MESHRepublic of Korea-
dc.subject.MESHRetrospective Studies-
dc.subject.MESHTomography, Optical Coherence-
dc.titleNon-Arteritic Ischemic Optic Neuropathy Following COVID-19 Vaccination in Korea: A Case Series-
dc.typeArticle-
dc.identifier.pmid36974402-
dc.identifier.urlhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10042731-
dc.subject.keywordCoronavirus Disease 2019 (COVID-19)-
dc.subject.keywordNon-Arteritic Anterior Ischemic Optic Neuropathy-
dc.subject.keywordSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-
dc.subject.keywordVaccination-
dc.contributor.affiliatedAuthorChung, SA-
dc.type.localJournal Papers-
dc.identifier.doi10.3346/JKMS.2023.38.E95-
dc.citation.titleJournal of Korean medical science-
dc.citation.volume38-
dc.citation.number12-
dc.citation.date2023-
dc.citation.startPagee95-
dc.citation.endPagee95-
dc.identifier.bibliographicCitationJournal of Korean medical science, 38(12). : e95-e95, 2023-
dc.identifier.eissn1598-6357-
dc.relation.journalidJ010118934-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Ophthalmology
Files in This Item:
36974402.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse